Bain Article: Medtech and Pharma Sales Go Virtual Companies need a mix of commercial models to meet new customer preferences and respond to restrictions on access to physicians. About 60% of surgeons believe that restrictions on in-person sales representative access are likely to persist even after a Covid-19 vaccine is available. Of the 75% of physicians who preferred in-person visits from medtech representatives prior to Covid-19, 47% now prefer virtual exchanges or less-frequent visits. Many physicians once skeptical of virtual interactions with sales reps now report these exchanges are high quality. Source: https://www.bain.com/insights/medtech-and-pharma-sales-go-virtual/
|
AboutIn this blog we review important trends and insights from global thought leaders including McKinsey, BCG Categories
All
Archives
September 2024
|